GENE ONLINE|News &
Opinion
Blog

2025-08-21|

SARS-CoV-2 Infects Leydig Cells and Disrupts Testosterone Production by Hijacking Cholesterol

by Mark Chiang
Share To

A recent study has revealed that SARS-CoV-2, the virus responsible for COVID-19, infects testicular cells and utilizes their cellular machinery to replicate. Researchers found that the virus targets Leydig cells, which are responsible for producing testosterone, and exploits their metabolic pathways as well as cholesterol—a key precursor in testosterone production—to facilitate its replication process. The findings also indicate that this interaction alters lipid metabolism within these cells.

The study highlights how SARS-CoV-2 hijacks critical functions of testicular cells to sustain its formation. By appropriating cholesterol and disrupting lipid metabolism, the virus appears to manipulate essential processes involved in hormone production. These insights provide a deeper understanding of how the virus interacts with host cells beyond respiratory tissues, shedding light on potential implications for reproductive health and hormonal balance during infection.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: August 21, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Scroll to Top